COMPANY
About US
History
R&D
Pipeline
Intellectual Property
Organization
BUSINESS
CDMO
CARE™ Platform
Partner
CONTACT
Contact
PUBLIC
Notice
News
EN
KO
COMPANY
About US
History
R&D
Pipeline
Intellectual Property
Organization
BUSINESS
CDMO
CARE™ Platform
Partner
CONTACT
Contact
PUBLIC
NOTICE
NEWS
PUBLIC
Notice
News
NEWS
전체
전체
제목
내용
GENIXCURE selected Biovian for manufacturing of AAV-based product for the treatment of Alzheimer’s disease.
2022-02-22
GENIXCURE, 시리즈A 125억..'miRNA 타깃 뇌질환신약'
2022-02-17
메디사피엔스와 AI기반 신약개발 MOU 체결
2022-01-19
제닉스큐어, 치매극복연구개발사업단 치매치료제개발 과제 선정
2021-01-11
제닉스큐어 '치매 치료물질 미국 특허 획득'
2021-01-11
제닉스큐어, miRNA 조절 AD 유전자치료제 개발
2021-01-08
1
2